Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon, causing symptoms such as bloody diarrhea and abdominal pain1 . It is a lifelong disorder with significant physical and mental health impacts, requiring ongoing management to induce and maintain remission and improve quality of life2 . Treatment strategies vary based on disease severity and aim to reduce symptoms, prevent complications, and support patients' well-being3 4.
Medication Treatments for Ulcerative Colitis
Treatment of UC primarily involves medications that induce remission during flare-ups and maintain remission long-term. The choice of therapy depends on disease severity, extent, and patient preferences5 .
Aminosalicylates, also called 5-ASAs, are anti-inflammatory drugs that reduce colon inflammation and promote healing4 . Mesalazine is the first-line treatment for mild-to-moderate UC of any extent and is recommended by all major guidelines6 . It rapidly induces clinical response and remission and sustains steroid-free remission with a safety profile similar to placebo6 . Mesalamine is available in various oral formulations such as tablets, capsules, and granules, designed for extended or delayed release to target different parts of the intestine6 . Rectal forms like suppositories and enemas are also used, especially for proctitis or left-sided colitis4 .
Sulfasalazine, another aminosalicylate, is an alternative option but is less commonly used due to side effects6 . Approximately 85% of UC cases are mild-to-moderate, making mesalazine a cornerstone therapy for most patients6 .
Corticosteroids are potent anti-inflammatory agents used to induce remission in patients who do not respond adequately to 5-ASAs4 . They can be administered orally, rectally, or intravenously depending on disease severity4 . Unlike 5-ASAs, corticosteroids are not recommended for long-term maintenance due to potential serious side effects such as bone weakening and eye problems4 . Short-term use may cause weight gain, mood changes, and sleep difficulties4 .
Immunomodulators suppress the immune system to reduce inflammation and are used in moderate-to-severe UC or when other treatments fail4 . Examples include thiopurines and tacrolimus suppositories4 . These agents may take weeks to months to become effective and require monitoring for infections and blood cell counts4 . They are often used as maintenance therapy after induction of remission7 .
Newer oral therapies called targeted synthetic small molecules include Janus kinase (JAK) inhibitors such as tofacitinib and filgotinib, and sphingosine-1-phosphate (S1P) receptor modulators like ozanimod and etrasimod8 9. These drugs block specific enzymes or receptors involved in the inflammatory process8 . They are indicated for moderate-to-severe UC patients who have not responded to standard or biologic therapies8 . These medications require regular monitoring due to potential risks, including increased infection susceptibility8 .
Biologic therapies are monoclonal antibodies targeting specific immune proteins to reduce intestinal inflammation8 . Approved biologics for UC include anti-TNF agents (infliximab, adalimumab, golimumab), anti-integrin (vedolizumab), IL-12/23p40 antibody (ustekinumab), and IL-23p19 inhibitors (guselkumab, mirikizumab, risankizumab) 810. These are administered via infusion or injection and are effective in inducing and maintaining remission in moderate-to-severe UC8 . Biosimilars are acceptable alternatives to originator biologics without treatment delays8 . Treatment response is monitored clinically and endoscopically to achieve deep remission7 .
| Medication Class | Examples | Use | Administration | Notes |
|---|---|---|---|---|
| Aminosalicylates (5-ASAs) | Mesalazine, Sulfasalazine | Mild-to-moderate UC | Oral, rectal | First-line, safe for long-term use6 4 |
| Corticosteroids | Prednisone, Budesonide MMX | Induction of remission | Oral, rectal, IV | Not for maintenance; short-term use only4 |
| Immunomodulators | Thiopurines, Tacrolimus | Moderate-to-severe UC | Oral, rectal | Slow onset; requires monitoring4 |
| Targeted Synthetic Small Molecules | Tofacitinib, Ozanimod, Etrasimod | Moderate-to-severe UC | Oral | Newer agents; risk of infections8 |
| Biologics | Infliximab, Vedolizumab, Ustekinumab | Moderate-to-severe UC | IV infusion, SC injection | Effective for induction and maintenance8 10 |
Surgical Procedures for Severe Cases
Surgery is considered for UC patients who fail medical therapy or develop severe complications11 12. Acute severe ulcerative colitis (ASUC) is a medical emergency with high morbidity and often requires colectomy despite advances in medical treatments11 . Toxic megacolon, a life-threatening complication characterized by rapid colon enlargement, demands immediate surgery if intensive drug therapy fails13 .
Up to 15% of UC patients may require surgery due to medication failure or risk of dysplasia and colorectal cancer from longstanding disease1 . Surgical options include:
- Proctocolectomy with Ileal Pouch-Anal Anastomosis (IPAA): Removal of colon and rectum with creation of an internal pouch from the small intestine connected to the anus, allowing normal defecation. This is the most common surgery for UC12 14.
- Proctocolectomy with End Ileostomy: Removal of colon, rectum, and anus with creation of a permanent external stoma (ileostomy) for waste collection12 14.
- Staged Procedures: Surgery may be done in one, two, or three stages depending on patient health and urgency12 .
- Emergency Surgery: Indicated for toxic megacolon, colon perforation, severe bleeding, or refractory disease11 12.
Postoperative recovery involves adjustment to changes in bowel habits and possible complications such as pouchitis (inflammation of the pouch) 12. Patients can often resume normal activities and maintain good quality of life after surgery12 .
Complementary and Alternative Medicine Options
Complementary therapies may support conventional UC treatment but require further research for definitive recommendations.
Polyphenols, natural compounds found in plants, have shown promising results as adjuvant therapy in UC. A meta-analysis of randomized controlled trials found higher clinical remission and response rates in patients receiving polyphenols compared to controls15 . However, the overall efficacy and safety remain controversial and need further validation15 .
Short-chain fatty acids (SCFAs), produced by gut bacteria, have potential benefits in UC treatment according to systematic reviews, but more clinical studies are necessary16 .
Current evidence does not support routine use of probiotics as primary or adjunctive therapy for induction or maintenance of remission in UC8 . More high-quality research is needed to establish their role.
There is limited data on acupuncture for UC, and it is not currently recommended as a primary treatment option8 .
Lifestyle Changes and Home Remedies
Lifestyle management is essential to complement medical therapy and improve overall well-being in UC patients.
Patients are advised to pay attention to their body's responses to foods. Avoiding gluten, grains, dairy, soy, and added sugars may reduce gas, bloating, and abdominal pain17 . Eating foods high in pectin, such as applesauce and bananas, can help thicken stool and control diarrhea, especially after surgery12 17. Adequate hydration with six to eight glasses of water daily is important12 .
Stress can exacerbate UC symptoms. Patients are encouraged to practice stress reduction techniques and seek mental health support when needed17 . Educational programs improve treatment adherence and clinical outcomes by increasing patient knowledge and coping skills2 .
Managing Daily Life with Ulcerative Colitis
Living with UC involves managing both physical symptoms and mental health challenges. The disease can be isolating and frustrating, but support from family, healthcare teams, and patient communities is vital17 . Educational guidelines have been shown to significantly improve adherence to treatment regimens, leading to better clinical outcomes2 .
Patients are encouraged to:
- Stay positive and focus on achievable goals17 .
- Connect with others through support groups or online communities17 .
- Ask for help from family and friends when needed17 .
- Maintain regular medical follow-ups and monitoring2 .
- Prioritize mental health alongside physical health17 .
“Things can and do get better. I suffered for years and I never thought I would get to a point where my day-to-day life wasn’t unbearably painful. Yet here I am, in remission, thanks to my and medication. Keep fighting and trying different things to improve your health, as one thing that might not work for someone else could work for you!”
— UC patient since 201617
Key Takeaways and Summary
- Ulcerative colitis is a chronic, lifelong inflammatory disease of the colon with significant physical and mental health impacts2 1.
- Mesalazine (5-ASA) is the first-line medication for mild-to-moderate UC, inducing and maintaining remission with a good safety profile6 18.
- Corticosteroids are effective for inducing remission but are not recommended for long-term maintenance due to side effects4 .
- Immunomodulators, targeted small molecules, and biologics provide options for moderate-to-severe UC and patients unresponsive to first-line therapies8 10.
- Surgery remains necessary in severe or complicated cases, with proctocolectomy and ileal pouch-anal anastomosis being common procedures11 12.
- Complementary therapies like polyphenols show promise but require more evidence; probiotics and acupuncture currently lack sufficient support15 8.
- Lifestyle modifications, including diet and stress management, support overall health and symptom control17 .
- Patient education and support improve treatment adherence and quality of life2 17.
